Pharmedic Pharmaceutical Medicinal JSC (HNX: PMC)

Market Cap	1.11T
Revenue (ttm)	498.18B
Net Income (ttm)	80.13B
Shares Out	9.33M
EPS (ttm)	6,268.00
PE Ratio	18.92
Forward PE	n/a
Dividend	19,100.00 (16.10%)
Ex-Dividend Date	Feb 18, 2025

Volume	2,337
Average Volume	4,382
Open	114,600
Previous Close	114,000
Day's Range	114,600 - 118,800
52-Week Range	73,600 - 135,800
Beta	0.34
RSI	56.23
Earnings Date	Jan 16, 2025

About HNX: PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the production and distribution of pharmaceutical products for the Vietnamese community. The company offers over-the-counter medicinal products, hepatobiliary systems, cardiovascular systems, respiratory systems, central nervous systems, Musculo-skeletal systems, hormones, anti-infectives, Genito-urinary systems, endocrine and metabolic systems, and vitamins and minerals, as well as eyes, ears, nose and throat, and cough treatment products. It also provides dermatological product...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 534
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2024, PMC's revenue was 498.18 billion, an increase of 2.68% compared to the previous year's 485.19 billion. Earnings were 80.13 billion, an increase of 31.36%.